Mesenchymal stem cells and secretome as modulators of neuroinflammation in neurological disorders
Yao D., Nie L., Liu X., Wu X., Tang Y., Pan C.
Narrative Review on Neuroinflammation, Immune Modulation, published in J Transl Med (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- J Transl Med (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41877113
- PMCID
- PMC13137692
- DOI
- 10.1186/s12967-026-08052-x
- Citations
- 1
Abstract (original English)
BACKGROUND: Neuroinflammation is a critical pathogenic driver in a wide spectrum of neurological disorders, contributing to significant morbidity and presenting a formidable therapeutic challenge. Among emerging regenerative approaches, mesenchymal stem cells (MSCs) have garnered significant attention for their potent capacity to modulate this detrimental immune response, offering hope for conditions ranging from acute brain injury to chronic neurodegeneration. OBJECTIVE: This review aims to comprehensively synthesize the current understanding of how MSCs and their secretome, particularly extracellular vesicles (EVs), therapeutically modulate neuroinflammation. We seek to elucidate the key molecular and cellular mechanisms of action and to critically evaluate the evidence for these therapies across various neurological disease models. EVIDENCE REVIEW: This review synthesizes the evolving literature on MSC-mediated immunomodulation, highlighting the therapeutic transition from cell replacement to secretome-based strategies. We examine pivotal studies elucidating the molecular mechanisms by which MSCs and their secretome regulate glial phenotypes and inflammatory pathways, preserve blood-brain barrier integrity, and modulate peripheral immune responses. Furthermore, we critically analyze therapeutic efficacy across preclinical models of acute and chronic neurological disorders an
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level ASystematic ReviewPubMed
The use of cellular therapies for trigeminal neuralgia: a systematic review of behavioral and molecular outcomes.
Systematic Review with a reported sample of 8 on Neuroinflammation, published in Neurosurg Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 8
Neurosurg Rev - Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level ASystematic ReviewEurope PMC
Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies
Systematic Review on Neuroinflammation, Skin Aging, published in Cureus (2026) — summary generated from the PubMed abstract.
- 2026
Cureus - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level ASystematic ReviewEurope PMC
Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Review
Systematic Review with a reported sample of 123 on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Biologics (2026) — summary generated from the PubMed abstract.
- 2026
- n = 123
Biologics